These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31707643)
1. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase. Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643 [TBL] [Abstract][Full Text] [Related]
2. The oculocerebrorenal syndrome of Lowe: an update. Bökenkamp A; Ludwig M Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217 [TBL] [Abstract][Full Text] [Related]
3. Novel pathogenic OCRL mutations and genotype-phenotype analysis of Chinese children affected by oculocerebrorenal syndrome: two cases and a literature review. Zhang Y; Deng L; Chen X; Hu Y; Chen Y; Chen K; Zhou J BMC Med Genomics; 2021 Sep; 14(1):219. PubMed ID: 34488756 [TBL] [Abstract][Full Text] [Related]
4. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome. Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960 [TBL] [Abstract][Full Text] [Related]
5. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. De Matteis MA; Staiano L; Emma F; Devuyst O Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993 [TBL] [Abstract][Full Text] [Related]
6. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome. Bothwell SP; Farber LW; Hoagland A; Nussbaum RL Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266 [TBL] [Abstract][Full Text] [Related]
7. Kidney Tubular Ablation of Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154 [TBL] [Abstract][Full Text] [Related]
8. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome. Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796 [TBL] [Abstract][Full Text] [Related]
9. Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome. Du R; Zhou C; Chen S; Li T; Lin Y; Xu A; Huang Y; Mei H; Huang X; Tan D; Zheng R; Liang C; Cai Y; Shao Y; Zhang W; Liu L; Zeng C Pediatr Nephrol; 2024 Aug; 39(8):2377-2391. PubMed ID: 38589698 [TBL] [Abstract][Full Text] [Related]
10. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease. Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522 [TBL] [Abstract][Full Text] [Related]
11. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. Zhang X; Hartz PA; Philip E; Racusen LC; Majerus PW J Biol Chem; 1998 Jan; 273(3):1574-82. PubMed ID: 9430698 [TBL] [Abstract][Full Text] [Related]
12. Novel mutation of OCRL1 in Lowe syndrome. Liu T; Yue Z; Wang H; Tong H; Sun L Indian J Pediatr; 2015 Jan; 82(1):89-92. PubMed ID: 25297642 [TBL] [Abstract][Full Text] [Related]
13. Novel OCRL mutations in Chinese children with Lowe syndrome. Zhang YQ; Wang F; Ding J; Yan H; Yang YL World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333 [TBL] [Abstract][Full Text] [Related]
14. Case report of fetus with Lowe syndrome: Expanding the prenatal phenotype. Burrill N; Khalek N; Oliver ER; Linn R; Victoria T; Yates C; Moldenhauer JS Prenat Diagn; 2024 May; 44(5):665-668. PubMed ID: 38554254 [TBL] [Abstract][Full Text] [Related]
15. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Recker F; Zaniew M; Böckenhauer D; Miglietti N; Bökenkamp A; Moczulska A; Rogowska-Kalisz A; Laube G; Said-Conti V; Kasap-Demir B; Niemirska A; Litwin M; Siteń G; Chrzanowska KH; Krajewska-Walasek M; Sethi SK; Tasic V; Anglani F; Addis M; Wasilewska A; Szczepańska M; Pawlaczyk K; Sikora P; Ludwig M Pediatr Nephrol; 2015 Jun; 30(6):931-43. PubMed ID: 25480730 [TBL] [Abstract][Full Text] [Related]
16. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells. Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM Mol Autism; 2018; 9():44. PubMed ID: 30147856 [TBL] [Abstract][Full Text] [Related]
17. A premature termination mutation in a patient with Lowe syndrome without congenital cataracts: dropping the "O" in OCRL. Pasternack SM; Böckenhauer D; Refke M; Tasic V; Draaken M; Conrad C; Born M; Betz RC; Reutter H; Ludwig M Klin Padiatr; 2013 Jan; 225(1):29-33. PubMed ID: 22915452 [TBL] [Abstract][Full Text] [Related]
18. Selective proximal renal tubular involvement and dyslipidemia in two cousins with oculocerebrorenal syndrome of Lowe. Topaloğlu R; Ludwig M; Çelebi Tayfur A Turk J Pediatr; 2013; 55(3):331-4. PubMed ID: 24217083 [TBL] [Abstract][Full Text] [Related]
19. Loss of OCRL increases ciliary PI(4,5)P Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046 [TBL] [Abstract][Full Text] [Related]